Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (ALNY) Q3 2023 Earnings

3AugConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-2.69

-2.26

-1.83

-1.4

Details

Expected EPS

-1.5

Actual EPS

-2.21

Surprise EPS

-0.71

Surprise Percent

+47.33%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -2.21 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.